116 related articles for article (PubMed ID: 3738908)
1. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients.
Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
Avgerinos A; Gorrod JW
Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule.
Myers MG; Raemsch KD
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S76-8. PubMed ID: 2455148
[TBL] [Abstract][Full Text] [Related]
5. Treatment of arterial hypertension with nifedipine in patients with chronic renal insufficiency.
Ambroso GC; Como G; Scalamogna A; Citterio A; Casati S; Ponticelli C
Clin Nephrol; 1985 Jan; 23(1):41-5. PubMed ID: 3978881
[TBL] [Abstract][Full Text] [Related]
6. The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.
Challenor V; Waller DG; Gruchy BS; Renwick AG; George CF; McMurdo ET; McEwen J
Br J Clin Pharmacol; 1986 Nov; 22(5):565-70. PubMed ID: 3790403
[TBL] [Abstract][Full Text] [Related]
7. Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.
Galletti F; Barba G; Nardecchia A; Strazzullo P; Scagliusi P; Pirrelli A; Mancini M
J Clin Pharmacol; 1994 Sep; 34(9):919-23. PubMed ID: 7983235
[TBL] [Abstract][Full Text] [Related]
8. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension.
Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817
[TBL] [Abstract][Full Text] [Related]
9. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
[TBL] [Abstract][Full Text] [Related]
10. Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine.
Banzet O; Colin JN; Thibonnier M; Singlas E; Alexandre JM; Corvol P
Eur J Clin Pharmacol; 1983; 24(2):145-50. PubMed ID: 6840159
[TBL] [Abstract][Full Text] [Related]
11. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
[TBL] [Abstract][Full Text] [Related]
12. Nifedipine: kinetics and dynamics in healthy subjects.
Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of a combination of a diuretic and nifedipine retard for the treatment of hypertensive patients refractory to nifedipine retard].
Martínez López JJ; Rúiz López FJ; Gómez Márquez M; Ortega González G; Molina Boix M; Florenciano Sánchez R
An Med Interna; 1993 Aug; 10(8):386-9. PubMed ID: 8218783
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients.
Uchino K; Isozaki S; Amano J; Tanaka N; Saitoh Y; Nakagawa F; Tamura Z; Oka H
J Pharmacobiodyn; 1983 Sep; 6(9):684-91. PubMed ID: 6655548
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.
Taburet AM; Singlas E; Colin JN; Banzet O; Thibonnier M; Corvol P
Hypertension; 1983; 5(4 Pt 2):II29-33. PubMed ID: 6345374
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients.
Kleinbloesem CH; van Brummelen P; Faber H; Breimer DD
J Cardiovasc Pharmacol; 1987 Feb; 9(2):202-8. PubMed ID: 2435999
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine-retard versus nifedipine-capsules for the therapy of hypertensive crisis in black patients.
Damasceno A; Sevene E; Patel S; Polónia J
J Cardiovasc Pharmacol; 1998 Jan; 31(1):165-9. PubMed ID: 9456291
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
Kirby BJ; Kitchin NR
Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
